Azvudine
CAS No. 1011529-10-4
Azvudine( RO 0622 )
Catalog No. M10071 CAS No. 1011529-10-4
Azvudine (RO 0622) is a potent HCV NS5B RNA polymerase inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 125 | In Stock |
|
| 10MG | 207 | In Stock |
|
| 25MG | 410 | In Stock |
|
| 50MG | 617 | In Stock |
|
| 100MG | 936 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAzvudine
-
NoteResearch use only, not for human use.
-
Brief DescriptionAzvudine (RO 0622) is a potent HCV NS5B RNA polymerase inhibitor.
-
DescriptionAzvudine (RO 0622) is a potent HCV NS5B RNA polymerase inhibitor, inhibits HCV replication in the replicon system with IC50 of 24 nM; inhibits RNA synthesis by HCV polymerases from either HCV genotypes 1a and 1b or containing S96T or S282T point mutations (IC50=10-100 nM).
-
In VitroAzvudine (RO-0622) displays strong inhibition on wild-type HIV-1IIIB and HIV-1RF with an EC50 ranging from 30 to 110 pM. The EC50 values of Azvudine against HIV-1KM018, HIV-1TC-1 and HIV-1WAN T69N are 6.92, 0.34 and 0.45 nM, respectively. Azvudine is sensitive to NRTIs-resistant strain HIV-174V, PIs-resistant strains HIV-1L10R/M46I/L63P/V82T/I84V and HIV-1RF V82F/184V, and FIs-resistant strain pNL4-3 gp41 (36G) V38A/N42T. The EC50 values of Azvudine against these resistant strains are 0.11, 0.14, 0.37 and 0.36 nM respectively.
-
In Vivo——
-
SynonymsRO 0622
-
PathwayMicrobiology/Virology
-
TargetHCV
-
RecptorHCV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1011529-10-4
-
Formula Weight286.223
-
Molecular FormulaC9H11FN6O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (436.73 mM)
-
SMILESO=C1N=C(N)C=CN1[C@H]2[C@@H](F)[C@@H]([C@](CO)(N=[N+]=[N-])O2)O
-
Chemical Name4-amino-1-[(2R,3S,4R,5R)-5-azido-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Klumpp K, et al. J Biol Chem. 2008 Jan 25;283(4):2167-75.
molnova catalog
related products
-
Pibrentasvir
Pibrentasvir (ABT-530) is a novel and pan-genotypic HCV NS5A inhibitor with EC50 of 1.4-5.0 pM against HCV replicons containing NS5A genotypes 1-6.
-
GSK-2336805
GSK-2336805 (JNJ-56914845) is a novel potent HCV NS5A inhibitor with multigenotype activity.
-
BMS-961955
BMS-961955 is an potent, allosteric inhibitor of HCV NS5B polymerase with EC50 of 7.9/4.3 nM for GT 1b/1a replicon respectively.
Cart
sales@molnova.com